Classification of migraine into different endophenotypes could aid diagnosis and treatment, but requires detailed characterization of different phenotypes. A new study provides insight into the clinical features of migraine with unilateral cranial autonomic symptoms, but raises questions about the value of such classifications.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
The Journal of Headache and Pain Open Access 01 November 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barbanti, P. et al. The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patients. Cephalalgia http://dx.doi.org/10.1177/0333102416630579 (2015).
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33, 629–808 (2013).
Anttila, V. et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat. Genet. 42, 869–873 (2010).
Anttila, V. et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat. Genet. 45, 912–917 (2013).
Gormley, P. et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine [abstract]. bioRχiv [online], (2015).
Amin, F. M. et al. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol. 12, 454–461 (2013).
Asghar, M. S. et al. Evidence for a vascular factor in migraine. Ann. Neurol. 69, 635–645 (2011).
Acknowledgements
The author is supported by a grant from the Candys Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Jes Olesen has received research support from and/or has consulted for and/or has been on the speakers' bureau of Alder Biopharmaceuticals and Curatis Pharma.
Rights and permissions
About this article
Cite this article
Olesen, J. Are migraine endophenotypes needed?. Nat Rev Neurol 12, 320–321 (2016). https://doi.org/10.1038/nrneurol.2016.31
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2016.31
This article is cited by
-
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
The Journal of Headache and Pain (2022)
-
Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine
Neurological Sciences (2019)